Katran Sevim Ezgi, Arkan Kevser, Oğlak Süleyman Cemil, Özçivit Erkan İpek Betül, Cebeci Gözde, Çelik Engin
Department of Obstetrics and Gynecology, Health Sciences University, Kanuni Sultan Suleiman Training and Research Hospital, Istanbul 34303, Turkey.
Department of Gynecologic Oncology, Health Sciences University, Gazi Yaşargil Training and Research Hospital, Diyarbakır 21500, Turkey.
J Clin Med. 2025 Jun 8;14(12):4059. doi: 10.3390/jcm14124059.
To evaluate the prognostic value of systemic inflammatory response (SIR) parameters in predicting the recurrence of cervical intraepithelial neoplasia (CIN2+) in women undergoing a loop electrosurgical excision procedure (LEEP). This retrospective study included women aged ≥18 years who underwent an LEEP at a tertiary center between 2013 and 2023. Patients who were pregnant and those who had malignancies, immune disorders, or prior cervical surgery were excluded. The data collected included age, parity, cervical cytology, HPV DNA status, histology, LEEP specimen size, and preoperative blood count parameters. Follow-up was performed every six months using cytology, colposcopy, and histology to assess recurrence. The SIR markers evaluated included the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), and lymphocyte count. Statistical analyses included ROC curves and Cox regression. Of the 1068 patients included, 726 had follow-up data, and 32 (4.4%) experienced a recurrence after a mean interval of 24 ± 20 months. Recurrence-negative patients had higher median lymphocyte counts (2.40 vs. 2.15, = 0.031) and LMRs (4.57 vs. 3.86, = 0.011). The disease-free survival period was longer in patients with high lymphocyte counts, a low NLR and PLR, and a high LMR. However, the discriminatory power of these markers was limited. In the multivariate analysis, only a PLR > 118.4 remained independently associated with an increased recurrence risk (HR 3.06, = 0.011). Due to the small number of cases of recurrences and the small amount of HPV DNA results, the findings should be interpreted with caution. Preoperative SIR markers such as the PLR, NLR, LMR, and lymphocyte count showed statistical associations with CIN2+ recurrence after an LEEP, but their clinical utility appears to be limited. Further prospective studies are needed to validate these findings.
评估全身炎症反应(SIR)参数在预测接受环形电切术(LEEP)的女性宫颈上皮内瘤变(CIN2+)复发中的预后价值。这项回顾性研究纳入了2013年至2023年在三级中心接受LEEP的年龄≥18岁的女性。排除怀孕以及患有恶性肿瘤、免疫疾病或既往有宫颈手术史的患者。收集的数据包括年龄、产次、宫颈细胞学检查、HPV DNA状态、组织学、LEEP标本大小和术前血常规参数。每六个月进行一次随访,采用细胞学、阴道镜检查和组织学评估复发情况。评估的SIR标志物包括中性粒细胞与淋巴细胞比值(NLR)、淋巴细胞与单核细胞比值(LMR)、血小板与淋巴细胞比值(PLR)和淋巴细胞计数。统计分析包括ROC曲线和Cox回归。在纳入的1068例患者中,726例有随访数据,32例(4.4%)在平均24±20个月的间隔后出现复发。复发阴性患者的淋巴细胞计数中位数较高(2.40对2.15,P = 0.031),LMR也较高(4.57对3.86,P = 0.011)。淋巴细胞计数高、NLR和PLR低以及LMR高的患者无病生存期更长。然而,这些标志物的鉴别能力有限。在多变量分析中,只有PLR>118.4仍与复发风险增加独立相关(HR 3.06,P = 0.011)。由于复发病例数少且HPV DNA结果数量少,这些发现应谨慎解读。术前SIR标志物如PLR、NLR、LMR和淋巴细胞计数与LEEP术后CIN2+复发存在统计学关联,但其临床实用性似乎有限。需要进一步的前瞻性研究来验证这些发现。